Relay Therapeutics Inc Strategic Asset Allocation Index
Relay Therapeutics Inc strategic asset allocation index. Relay Therapeutics Inc (RLAY) has a Strategic Asset Allocation Index of 9.0% as of June 2023. Strategic assets (PP&E of $72.66 Million plus long-term investments of $-) total $72.66 Million, measured against net assets of $810.12 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check RLAY goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Relay Therapeutics Inc (2020–2022)
Strategic asset allocation index of Relay Therapeutics Inc from 2020 to 2022. This chart shows how Relay Therapeutics Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of June 2023, the index stands at 9.0%, representing strategic assets of $72.66 Million against net assets of $810.12 Million USD.
Relay Therapeutics Inc Strategic Asset Allocation Index by Year (2020–2022)
Relay Therapeutics Inc strategic asset allocation index by year from 2020 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Relay Therapeutics Inc from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Relay Therapeutics Inc (RLAY) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.2% | $11.63 Million | $11.63 Million | $- | $950.22 Million | ▲ +0.5 pp |
| 2021 | 0.7% | $6.54 Million | $6.54 Million | $- | $897.81 Million | ▼ -3.0 pp |
| 2020 | 3.8% | $28.83 Million | $28.83 Million | $- | $763.29 Million | — |